Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jun 12 04:00PM ET
156.66
Dollar change
+1.40
Percentage change
0.90
%
IndexDJIA, S&P 500 P/E17.41 EPS (ttm)9.00 Insider Own0.14% Shs Outstand2.41B Perf Week1.95%
Market Cap376.94B Forward P/E14.11 EPS next Y11.10 Insider Trans-0.60% Shs Float2.40B Perf Month5.54%
Income21.81B PEG2.95 EPS next Q2.68 Inst Own73.52% Short Float0.80% Perf Quarter-3.88%
Sales89.33B P/S4.22 EPS this Y6.33% Inst Trans0.53% Short Ratio2.15 Perf Half Y4.72%
Book/sh32.47 P/B4.82 EPS next Y4.61% ROA11.93% Short Interest19.22M Perf Year6.48%
Cash/sh16.12 P/C9.72 EPS next 5Y5.90% ROE29.45% 52W Range140.68 - 169.99 Perf YTD8.33%
Dividend Est.5.14 (3.28%) P/FCF18.50 EPS past 5Y0.55% ROIC18.73% 52W High-7.84% Beta0.41
Dividend TTM5.02 (3.20%) Quick Ratio1.03 Sales past 5Y1.58% Gross Margin68.24% 52W Low11.36% ATR (14)2.30
Dividend Ex-DateMay 27, 2025 Current Ratio1.26 EPS Y/Y TTM29.21% Oper. Margin23.83% RSI (14)57.30 Volatility0.76% 0.77%
Employees138100 Debt/Eq0.67 Sales Y/Y TTM-0.37% Profit Margin24.41% Recom2.20 Target Price170.84
Option/ShortYes / Yes LT Debt/Eq0.49 EPS Q/Q238.80% Payout84.80% Rel Volume0.79 Prev Close155.26
Sales Surprise1.55% EPS Surprise7.33% Sales Q/Q2.39% EarningsApr 15 BMO Avg Volume8.95M Price156.66
SMA201.87% SMA501.74% SMA2000.19% Trades Volume7,075,511 Change0.90%
Date Action Analyst Rating Change Price Target Change
May-13-25Downgrade Leerink Partners Outperform → Market Perform $153
Dec-10-24Resumed BofA Securities Neutral $166
Nov-15-24Initiated Wolfe Research Outperform $190
Jul-23-24Downgrade Daiwa Securities Outperform → Neutral $160 → $150
May-30-24Resumed Goldman Neutral $160
Apr-18-24Upgrade HSBC Securities Hold → Buy $170
Dec-13-23Downgrade Wells Fargo Overweight → Equal Weight $170 → $163
Dec-01-23Upgrade UBS Neutral → Buy $167 → $180
Oct-05-23Initiated RBC Capital Mkts Outperform $178
Sep-06-23Initiated HSBC Securities Hold $175
Today 04:25AM
Jun-12-25 11:57AM
11:00AM
05:40AM
Jun-11-25 04:45PM
10:57AM Loading…
10:57AM
10:20AM
09:50AM
09:36AM
09:34AM
08:05AM
07:00AM
06:20AM
06:20AM
05:35AM
05:00AM Loading…
05:00AM
Jun-10-25 04:51PM
04:25PM
03:52PM
10:10AM
09:02AM
06:20AM
Jun-09-25 11:33AM
05:53AM
Jun-07-25 03:00PM
05:59AM
Jun-06-25 04:16PM
04:08PM
09:33AM
07:39AM
09:00AM Loading…
Jun-05-25 09:00AM
Jun-04-25 12:17PM
05:00AM
04:48AM
Jun-03-25 05:45PM
04:57PM
04:41PM
11:02AM
10:45AM
10:45AM
10:45AM
09:40AM
08:00AM
06:41AM
04:00AM
Jun-02-25 10:42AM
08:43AM
08:23AM
May-30-25 08:18AM
May-29-25 12:53PM
11:53AM
06:21AM
May-28-25 05:45PM
04:43PM
10:08AM
May-27-25 11:19AM
07:30AM
May-25-25 07:07AM
04:10AM
May-24-25 04:16AM
May-23-25 08:00AM
06:20AM
May-22-25 05:45PM
11:00AM
09:07AM
08:46AM
05:20AM
May-21-25 04:40PM
09:00AM
08:50AM
08:21AM
06:20AM
May-20-25 11:21PM
06:21PM
12:24PM
06:16AM
06:00AM
May-19-25 12:09PM
09:08AM
May-18-25 04:32PM
03:25PM
12:33PM
May-17-25 12:20PM
09:30AM
06:40AM
May-16-25 03:08PM
09:40AM
May-15-25 05:48PM
11:30AM
06:49AM
May-14-25 04:40PM
11:00AM
May-13-25 09:41PM
05:08PM
04:53PM
04:18PM
02:47PM
09:56AM
09:22AM
08:21AM
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
REED JOHN CEVP, Innovative Medicine, R&DMay 01 '25Option Exercise0.0025,255040,797May 05 05:10 PM
Decker Robert JVP Corporate ControllerFeb 25 '25Option Exercise101.876,999712,98828,000Feb 26 06:42 PM
Decker Robert JVP Corporate ControllerFeb 25 '25Sale165.886,9991,160,99421,001Feb 26 06:42 PM
Decker Robert JOfficerFeb 25 '25Proposed Sale165.886,9991,161,010Feb 25 03:05 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 14 '25Option Exercise0.002,806017,904Feb 18 09:46 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 15 '25Option Exercise0.001,029015,501Feb 18 09:33 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 14 '25Option Exercise0.001,765015,111Feb 18 09:33 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 13 '25Option Exercise0.00499013,539Feb 18 09:33 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 18 '25Sale156.1540362,92815,098Feb 18 09:33 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 15 '25Option Exercise0.00607091,037Feb 18 09:16 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 14 '25Option Exercise0.007,367096,674Feb 18 09:16 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 13 '25Option Exercise0.00651089,603Feb 18 09:16 PM
Wolk Joseph JExec VP, CFOFeb 15 '25Option Exercise0.001,97106,113Feb 18 09:13 PM
Wolk Joseph JExec VP, CFOFeb 14 '25Option Exercise0.0019,330020,661Feb 18 09:13 PM
Wolk Joseph JExec VP, CFOFeb 13 '25Option Exercise0.001,77901,779Feb 18 09:13 PM
REED JOHN CEVP, Innovative Medicine, R&DFeb 15 '25Option Exercise0.001,350015,927Feb 18 09:11 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 15 '25Option Exercise0.001,5940171,110Feb 18 09:08 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 14 '25Option Exercise0.0019,5180185,924Feb 18 09:08 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 13 '25Option Exercise0.001,3020167,221Feb 18 09:08 PM
Swanson James D.EVP, CIOFeb 15 '25Option Exercise0.00492016,762Feb 18 09:06 PM
Swanson James D.EVP, CIOFeb 14 '25Option Exercise0.005,079019,739Feb 18 09:06 PM
Swanson James D.EVP, CIOFeb 13 '25Option Exercise0.00447015,019Feb 18 09:06 PM
Mulholland KristenEVP, Chief HR OfficerFeb 15 '25Option Exercise0.00419013,095Feb 18 09:05 PM
Mulholland KristenEVP, Chief HR OfficerFeb 14 '25Option Exercise0.002,608014,576Feb 18 09:05 PM
Mulholland KristenEVP, Chief HR OfficerFeb 13 '25Option Exercise0.00411012,100Feb 18 09:05 PM
Forminard ElizabethExecutive VP, General CounselFeb 15 '25Option Exercise0.00961010,321Feb 18 09:03 PM
Forminard ElizabethExecutive VP, General CounselFeb 14 '25Option Exercise0.002,203011,366Feb 18 09:03 PM
Forminard ElizabethExecutive VP, General CounselFeb 13 '25Option Exercise0.0065108,991Feb 18 09:03 PM
Duato JoaquinCEO and Chairman of the BoardFeb 15 '25Option Exercise0.003,6820397,525Feb 18 09:02 PM
Duato JoaquinCEO and Chairman of the BoardFeb 14 '25Option Exercise0.0024,3350415,205Feb 18 09:02 PM
Duato JoaquinCEO and Chairman of the BoardFeb 13 '25Option Exercise0.003,4700392,498Feb 18 09:02 PM
Decker Robert JVP Corporate ControllerFeb 15 '25Option Exercise0.00339020,116Feb 18 09:01 PM
Decker Robert JVP Corporate ControllerFeb 14 '25Option Exercise0.002,201021,373Feb 18 09:01 PM
Decker Robert JVP Corporate ControllerFeb 13 '25Option Exercise0.00312019,285Feb 18 09:01 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 15 '25Option Exercise0.00492021,839Feb 18 08:58 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 14 '25Option Exercise0.004,740024,591Feb 18 08:58 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 13 '25Option Exercise0.00408020,242Feb 18 08:58 PM
Duato JoaquinCEO and Chairman of the BoardFeb 07 '25Option Exercise100.06126,36912,644,482489,671Feb 11 07:43 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 07 '25Option Exercise100.0632,7623,278,166115,028Feb 11 07:42 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 07 '25Option Exercise100.0658,5045,853,910213,355Feb 11 07:41 PM
Wolk Joseph JExec VP, CFOFeb 07 '25Option Exercise100.0613,0151,302,28113,015Feb 11 07:40 PM
Wolk Joseph JExec VP, CFOFeb 07 '25Sale153.8913,0152,002,8780Feb 11 07:40 PM
Wolk Joseph JOfficerFeb 07 '25Proposed Sale153.8913,0152,002,924Feb 07 01:27 PM
WEINBERGER MARK ADirectorDec 12 '24Buy147.221,000147,2201,000Dec 12 05:27 PM
Hait WilliamFormer OfficerDec 04 '24Proposed Sale149.9025,7423,858,598Dec 04 01:25 PM
Decker Robert JVP Corporate ControllerAug 30 '24Option Exercise100.065,635563,83824,608Sep 03 04:48 PM
Decker Robert JVP Corporate ControllerAug 30 '24Sale165.065,635930,11318,973Sep 03 04:48 PM
Decker Robert JOfficerAug 30 '24Proposed Sale165.065,635930,113Aug 30 03:51 PM
Broadhurst VanessaEVP, Global Corp AffairsJul 08 '24Option Exercise0.009,809024,852Jul 09 05:48 PM